These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1818225)

  • 1. Immunotherapy of cryptosporidiosis in immunodeficient animal models.
    Perryman LE; Bjorneby JM
    J Protozool; 1991; 38(6):98S-100S. PubMed ID: 1818225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity.
    Ungar BL; Kao TC; Burris JA; Finkelman FD
    J Immunol; 1991 Aug; 147(3):1014-22. PubMed ID: 1677668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of egg yolk antibody on experimental Cryptosporidium parvum infection in scid mice.
    Kobayashi C; Yokoyama H; Nguyen SV; Kodama Y; Kimata T; Izeki M
    Vaccine; 2004 Nov; 23(2):232-5. PubMed ID: 15531042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptosporidium parvum merozoites share neutralization-sensitive epitopes with sporozoites.
    Bjorneby JM; Riggs MW; Perryman LE
    J Immunol; 1990 Jul; 145(1):298-304. PubMed ID: 2193057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
    Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.
    Riggs MW; Cama VA; Leary HL; Sterling CR
    Infect Immun; 1994 May; 62(5):1927-39. PubMed ID: 8168959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes.
    Mead JR; Arrowood MJ; Healey MC; Sidwell RW
    J Protozool; 1991; 38(6):59S-61S. PubMed ID: 1818204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites.
    Riggs MW; Stone AL; Yount PA; Langer RC; Arrowood MJ; Bentley DL
    J Immunol; 1997 Feb; 158(4):1787-95. PubMed ID: 9029117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptosporidium parvum infection in experimentally infected mice: infection dynamics and effect of immunosuppression.
    Tarazona R; Blewett DA; Carmona MD
    Folia Parasitol (Praha); 1998; 45(2):101-7. PubMed ID: 9684319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum.
    Bjorneby JM; Hunsaker BD; Riggs MW; Perryman LE
    Infect Immun; 1991 Mar; 59(3):1172-6. PubMed ID: 1997419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
    Hikosaka K; Satoh M; Koyama Y; Nakai Y
    Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
    Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA
    J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets for detection and immunotherapy in Cryptosporidium parvum.
    Boulter-Bitzer JI; Lee H; Trevors JT
    Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from Cryptosporidium parvum infection by gammadelta T cells in mice that lack alphabeta T cells.
    Eichelberger MC; Suresh P; Rehg JE
    Comp Med; 2000 Jun; 50(3):270-6. PubMed ID: 10894490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficiency mice.
    Rohlman VC; Kuhls TL; Mosier DA; Crawford DL; Greenfield RA
    J Parasitol; 1993 Apr; 79(2):295-7. PubMed ID: 8459345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility dynamics in neonatal BALB/c mice infected with Cryptosporidium parvum.
    Novak SM; Sterling CR
    J Protozool; 1991; 38(6):103S-104S. PubMed ID: 1818125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
    Aguirre SA; Perryman LE; Davis WC; McGuire TC
    J Immunol; 1998 Aug; 161(4):1891-900. PubMed ID: 9712058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
    Urban JF; Fayer R; Chen SJ; Gause WC; Gately MK; Finkelman FD
    J Immunol; 1996 Jan; 156(1):263-8. PubMed ID: 8598471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Rasmussen KR; Healey MC; Cheng L; Yang S
    J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.